Teva Pharma (TEVA) Tops Q2 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 42.26 +1.56 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.70 | 52 Week High | $66.55 | |||
| Open | $41.91 | 52 Week Low | $37.82 | |||
| Day High | $43.34 | P/E | N/A | |||
| Day Low | $41.54 | EPS | $0.00 | |||
| Volume | 7,334,609 | |||||
